Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair. 

Recurrent MR after TEER: Tracking data from nearly 700 MitraClip patients

The new analysis focused on both primary and secondary MR 12 months after TEER. 

New risk score predicts mortality after TEER

Researchers developed the new algorithm by identifying eight key factors associated with mortality among TEER patients. 

Tricuspid valve annuloplasty during mitral valve surgery offers key benefits

The new analysis focused on 98 patients who presented with primary mitral regurgitation.

Performing TAVR and TMVR during the same hospitalization may provide value

Patients undergoing both procedures at once tended to be sicker, but their risk of poor outcomes did not significantly increase. 

Thumbnail

New risk calculator detects TEER patients who may need to be readmitted for HF

Once the tool's performance is properly validated, it could help clinicians deliver better patient care and result in significant cost savings for health systems.

Thumbnail

TMVR with transfemoral access a 'promising option,’ early data suggest

Researchers reported at TCT 2021 that survival was 100% after 30 days.

Two-year outcomes highlight the value of TMVR for patients with severe MR

Patients continue to see the benefits of transcatheter mitral valve replacement a full two years after treatment.

Thumbnail

Mitral valve prolapse during pregnancy linked to higher risk of cardiac complications

MVP also appears to increase the risk of certain problems during childbirth. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup